Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Thuy Vu
Sr Research Scientist
Precision Oncology Decision Support
https://orcid.org/0000-0002-8163-6144
h-index
664
Citations
6
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2011
2025
Research activity per year
Overview
Fingerprint
Network
Research output
(7)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Thuy Vu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Precision Oncology
80%
Tumor
57%
Functional Impact
50%
CSN5
50%
Cell Cycle Regulators
50%
Trastuzumab
50%
Personalized Medication
50%
Mechanism of Action
50%
Breast Cancer
50%
Resistance Mechanisms
50%
Uncertain Significance
50%
Variants of Uncertain Significance
50%
Cancer Metabolic Reprogramming
50%
Model Precision
50%
Patient-derived Xenograft
50%
Biliary Tract Cancer
50%
Tumor Metabolism
33%
Decision Support
30%
Molecular Mechanism
25%
Tumor Volume
21%
Genetic Modification
17%
Tumorigenic Transformation
16%
Breast Cancer Patients
16%
Metabolic Programming
16%
Mitochondrial Biogenesis
16%
Glucose Uptake
16%
Metabolic Processes
16%
Tumor-promoting
16%
Expression Level
16%
Targeted Cancer Therapy
16%
Metabolic Gene Expression
16%
Glycolysis
16%
Therapy Development
16%
Do-it-yourself
16%
Cancer Hallmarks
16%
Polyubiquitination
16%
C-Myc
16%
Glucose Metabolic
16%
Metabolism
16%
Metabolic Shift
16%
Cellular Energy Metabolism
16%
Promising Direction
16%
Recurrence-free Survival
16%
Glutaminolysis
16%
Progressive Disease
14%
Partial Response
14%
Investigational Agents
14%
Malignancy
14%
RNA Sequencing (RNA-seq)
14%
First Foods
12%
Medicine and Dentistry
Trastuzumab
100%
Breast Cancer
75%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
58%
Oncology
50%
Combination Drug
50%
Xenograft
50%
Precision Oncology
50%
Biliary Tract Cancer
50%
Neoplasm
50%
Biliary Duct Cancer
20%
Progressive Disease
20%
Cancer
20%
RNA Sequence
20%
Diseases
18%
Combination Therapy
16%
Protein Expression
16%
Disease Exacerbation
16%
Cell Viability Assay
16%
Functional Genomics
16%
Metastatic Carcinoma
16%
Antibody-Drug Conjugate
10%
Exome Sequencing
10%
Fibroblast Growth Factor Receptor 2
10%
Genome Sequencing
10%
Event Free Survival
10%
Isocitrate Dehydrogenase
10%
Molecular Profiling
10%
Cancer Model
10%
Biopsy Technique
10%
Antineoplastic Activity
10%
Biological Marker
8%
Cancer Therapy
8%
Overall Survival
8%
Targeted Therapy
8%
Clinical Management
8%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Next Generation Sequencing
50%
CCAAT Enhancer Binding Protein Beta
50%
Cell Viability
50%
Reprogramming
50%
Protein Expression
50%
Cell Cycle
50%
Functional Genomics
50%
Gene Frequency
25%
Clinical Decision Making
25%
Metabolic Pathway
25%
Clinical Trial
25%
Ubiquitination
12%
Glucose Transport
12%
Recurrence Free Survival
12%
Mitochondrial Biogenesis
12%
Survival Rate
12%
Energy Metabolism
12%
Cell Energy
12%
Oncogene C Myc
12%
Anticancer
12%
Glutaminolysis
12%
Gene Expression
12%
